Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Overexpression of HIF1 Alpha Predicts Worse Overall and Event-Free Survival in Patients with Philadelphia Chromosome-Negative Precursor B-Lymphoblastic Leukemia

S. Konoplev, S.M. Kornblau, E. Schlette, H Lu, D. A Thomas, N Zhang, Y.H. Qiu, K Coombes, S. Neeley, Hagop M Kantarjian, L.J. Medeiros, M. Andreeff, M. Konopleva

Blood (2008) 112 (11): 2508.

https://doi.org/10.1182/blood.V112.11.2508.2508

Published: 2008

Journal Articles

Salvage Therapy with Combined Cyclophosphamide (C), Fludarabine (F), Alemtuzumab (A), and Rituximab (R) (CFAR) for Heavily Pre-Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, A. Ferrajoli, MD, S. Faderl, MD, C. Koller, MD, F. Giles, MD, J. Cortes, MD, D. Thomas, MD, F. Ravandi, MD, G. Garcia-Manero, MD, M. Andreeff, MD, S. Lerner, MS, H. Kantarjian, MD, M. Keating, MD

Blood (2005) 106 (11): 719.

https://doi.org/10.1182/blood.V106.11.719.719

Published: 2005

Journal Articles

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax

M Lisovsky, Z Estrov, X Zhang, U Consoli, G Sanchez-Williams, V Snell, R Munker, A Goodacre, V Savchenko, M Andreeff

Blood (1996) 88 (10): 3987–3997.

https://doi.org/10.1182/blood.V88.10.3987.bloodjournal88103987

Published: 1996

Journal Articles

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

M Beran, H Kantarjian, S O'Brien, C Koller, M al-Bitar, S Arbuck, S Pierce, M Moore, JL Abbruzzese, M Andreeff, M Keating, E Estey

Blood (1996) 88 (7): 2473–2479.

https://doi.org/10.1182/blood.V88.7.2473.bloodjournal8872473

Published: 1996

Journal Articles

A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia

R Munker, T Kobayashi, E Elstner, AW Norman, M Uskokovic, W Zhang, M Andreeff, HP Koeffler

Blood (1996) 88 (6): 2201–2209.

https://doi.org/10.1182/blood.V88.6.2201.bloodjournal8862201

Published: 1996

Journal Articles

Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes

J Drach, A Gsur, G Hamilton, S Zhao, J Angerler, M Fiegl, N Zojer, M Raderer, I Haberl, M Andreeff, H Huber

Blood (1996) 88 (5): 1747–1754.

https://doi.org/10.1182/blood.V88.5.1747.1747

Published: 1996

Journal Articles

The novel anthracycline annamycin is not affected by P-glycoprotein- related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines

U Consoli, W Priebe, YH Ling, R Mahadevia, M Griffin, S Zhao, R Perez-Soler, M Andreeff

Blood (1996) 88 (2): 633–644.

https://doi.org/10.1182/blood.V88.2.633.bloodjournal882633

Published: 1996

Journal Articles

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results [published erratum appears in Blood 1996 Jun 1;87(11):4922]

A Younes, A Sarris, U Consoli, A Rodriguez, P McLaughlin, Y Huh, S Starry, F Cabanillas, M Andreeff

Blood (1996) 87 (5): 1698–1703.

https://doi.org/10.1182/blood.V87.5.1698.1698

Published: 1996

Journal Articles

Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase

S O'Brien, H Kantarjian, M Keating, M Beran, C Koller, LE Robertson, J Hester, MB Rios, M Andreeff, M Talpaz

Blood (1995) 86 (9): 3322–3326.

https://doi.org/10.1182/blood.V86.9.3322.bloodjournal8693322

Published: 1995

Journal Articles

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

M Korbling, YO Huh, A Durett, N Mirza, P Miller, H Engel, P Anderlini, K van Besien, M Andreeff, D Przepiorka

Blood (1995) 86 (7): 2842–2848.

https://doi.org/10.1182/blood.V86.7.2842.2842

Published: 1995

Journal Articles

In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study

S Vadhan-Raj, HE Broxmeyer, M Andreeff, JC Bandres, ES Buescher, RS Benjamin, NE Papadopoulos, A Burgess, S Patel, C Plager

Blood (1995) 86 (6): 2098–2105.

https://doi.org/10.1182/blood.V86.6.2098.bloodjournal8662098

Published: 1995

Journal Articles

The PML gene encodes a phosphoprotein associated with the nuclear matrix

KS Chang, YH Fan, M Andreeff, J Liu, ZM Mu

Blood (1995) 85 (12): 3646–3653.

https://doi.org/10.1182/blood.V85.12.3646.bloodjournal85123646

Published: 1995

Journal Articles

Decreased expression of the deleted in colorectal carcinoma gene in non- Hodgkin's lymphoma

A Younes, S Zhao, D Jendiroba, HD Kleine, F Cabanillas, M Andreeff

Blood (1995) 85 (10): 2813–2816.

https://doi.org/10.1182/blood.V85.10.2813.bloodjournal85102813

Published: 1995

Journal Articles

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

SM Escudier, JM Pereira-Leahy, JW Drach, HU Weier, AM Goodacre, MA Cork, JM Trujillo, MJ Keating, M Andreeff

Blood (1993) 81 (10): 2702–2707.

https://doi.org/10.1182/blood.V81.10.2702.2702

Published: 1993

Journal Articles

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments]

D Drach, S Zhao, J Drach, R Mahadevia, C Gattringer, H Huber, M Andreeff

Blood (1992) 80 (11): 2729–2734.

https://doi.org/10.1182/blood.V80.11.2729.2729

Published: 1992

Journal Articles

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation- inducing agent

M Andreeff, R Stone, J Michaeli, CW Young, WP Tong, H Sogoloff, T Ervin, D Kufe, RA Rifkind, PA Marks

Blood (1992) 80 (10): 2604–2609.

https://doi.org/10.1182/blood.V80.10.2604.2604

Published: 1992

Journal Articles

High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia [see comments]

AH Sarris, S Kempin, E Berman, J Michaeli, C Little, M Andreeff, T Gee, D Straus, B Gansbacher, D Filippa

Blood (1992) 79 (5): 1305–1310.

https://doi.org/10.1182/blood.V79.5.1305.1305

Published: 1992

Journal Articles

Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression

F Herrmann, M Andreeff, HJ Gruss, MA Brach, M Lubbert, R Mertelsmann

Blood (1991) 78 (8): 2070–2074.

https://doi.org/10.1182/blood.V78.8.2070.2070

Published: 1991

Journal Articles

Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

E Berman, G Heller, J Santorsa, S McKenzie, T Gee, S Kempin, S Gulati, M Andreeff, J Kolitz, J Gabrilove

Blood (1991) 77 (8): 1666–1674.

https://doi.org/10.1182/blood.V77.8.1666.1666

Published: 1991

Journal Articles

Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia

P Bettelheim, P Valent, M Andreeff, A Tafuri, J Haimi, C Gorischek, M Muhm, C Sillaber, O Haas, L Vieder

Blood (1991) 77 (4): 700–711.

https://doi.org/10.1182/blood.V77.4.700.700

Published: 1991

NARROW

Overexpression of HIF1 Alpha Predicts Worse Overall and Event-Free Survival in Patients with Philadelphia Chromosome-Negative Precursor B-Lymphoblastic Leukemia

Salvage Therapy with Combined Cyclophosphamide (C), Fludarabine (F), Alemtuzumab (A), and Rituximab (R) (CFAR) for Heavily Pre-Treated Patients with CLL.

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia

Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes

The novel anthracycline annamycin is not affected by P-glycoprotein- related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results [published erratum appears in Blood 1996 Jun 1;87(11):4922]

Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study

The PML gene encodes a phosphoprotein associated with the nuclear matrix

Decreased expression of the deleted in colorectal carcinoma gene in non- Hodgkin's lymphoma

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments]

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation- inducing agent

High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia [see comments]

Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression

Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only